Skip to main content
Premium Trial:

Request an Annual Quote

Sequencing Stats

Premium

More than 200 people responded to our sequencing survey to give us a glimpse of trends in the field. The majority of respondents told us they performed sequencing for biomedical research, and there was a close to even split among people who said they used sequence data to study particular genes, SNPs, and to verify cloned genes for protein experiments. The debate between draft and finished sequence is still very much alive: in a photo finish, 52 percent of respondents said draft was fine, while 48 percent said finished sequence would serve researchers better. Here you’ll find some of the other data we gleaned from the survey.

File Attachments
The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.